EGFR-TKI rechallenged treatment combined with apatinib in non-small cell lung cancer with EGFR-TKI resistance.

Liang, L; Li, F; Cao, BS; Zhang, ZH; Zhu, X; Wang, JD

JOURNAL OF CLINICAL ONCOLOGY, 2017; 35 ( ):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索